|
Powered by Cell Signaling Technology |
| Site Information |
|---|
| PAVTSAGtPKRVIVQ SwissProt Entrez-Gene |
| Blast this site against: NCBI SwissProt PDB |
| Site Group ID: 471393 |
| In vivo Characterization | |
|---|---|
| Methods used to characterize site in vivo: | |
| Disease tissue studied: | |
| Relevant cell line - cell type - tissue: | |
| Upstream Regulation | |
|---|---|
| Putative in vivo kinases: | |
| Kinases, in vitro: | |
| Treatments: | |
| Downstream Regulation | |
|---|---|
| Effects of modification on CDK5R1: | |
| Effects of modification on biological processes: | |
| References | |
|---|---|
|
Borenäs M, et al. (2024) ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proc Natl Acad Sci U S A 121, e2315242121
38154064 Curated Info |
|
|
Takasugi T, et al. (2016) Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination. J Biol Chem 291, 4649-57
26631721 Curated Info |
|
|
Asada A, Saito T, Hisanaga S (2012) Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. J Cell Sci 125, 3421-9
22467861 Curated Info |
|
|
He L, et al. (2011) The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein. Cell Mol Life Sci 68, 1633-43
20976519 Curated Info |
|
|
Son MY, Chung SH (2010) Expression of p25, an aberrant cyclin-dependent kinase 5 activator, stimulates basal secretion in PC12 cells. Mol Cells 29, 51-6
20033852 Curated Info |
|
|
He L, Hou Z, Qi RZ (2008) Calmodulin binding and Cdk5 phosphorylation of p35 regulate its effect on microtubules. J Biol Chem 283, 13252-60
18326489 Curated Info |
|
|
Kamei H, et al. (2007) Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J Biol Chem 282, 1687-94
17121855 Curated Info |